These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23499668)

  • 1. PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity studies.
    Liu Y; Yang K; Cheng L; Zhu J; Ma X; Xu H; Li Y; Guo L; Gu H; Liu Z
    Nanomedicine; 2013 Oct; 9(7):1077-88. PubMed ID: 23499668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.
    Liang PC; Chen YC; Chiang CF; Mo LR; Wei SY; Hsieh WY; Lin WL
    Int J Nanomedicine; 2016; 11():2021-37. PubMed ID: 27274233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
    J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma.
    Shen C; Wang X; Zheng Z; Gao C; Chen X; Zhao S; Dai Z
    Int J Nanomedicine; 2019; 14():101-117. PubMed ID: 30587988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-Responsive, Self-Sacrificial Nanotheranostic Agent for Potential In Vivo and In Vitro Dual Modal MRI/CT Imaging, Real-Time, and In Situ Monitoring of Cancer Therapy.
    Yue L; Wang J; Dai Z; Hu Z; Chen X; Qi Y; Zheng X; Yu D
    Bioconjug Chem; 2017 Feb; 28(2):400-409. PubMed ID: 28042941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic effect and MR molecular imaging of FA-PEG-FePt/DDP nanoliposomes in AMF on ovarian cancer.
    Bian X; Guo T; Chen G; Nie D; Yue M; Zhu Y; Lin M
    Int J Nanomedicine; 2024; 19():5227-5243. PubMed ID: 38855734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Steeber DA; Gong S
    Biomaterials; 2010 Dec; 31(34):9065-73. PubMed ID: 20828811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetite nanocluster@poly(dopamine)-PEG@ indocyanine green nanobead with magnetic field-targeting enhanced MR imaging and photothermal therapy in vivo.
    Wu M; Wang Q; Zhang D; Liao N; Wu L; Huang A; Liu X
    Colloids Surf B Biointerfaces; 2016 May; 141():467-475. PubMed ID: 26896652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron oxide-gold core-shell nano-theranostic for magnetically targeted photothermal therapy under magnetic resonance imaging guidance.
    Abed Z; Beik J; Laurent S; Eslahi N; Khani T; Davani ES; Ghaznavi H; Shakeri-Zadeh A
    J Cancer Res Clin Oncol; 2019 May; 145(5):1213-1219. PubMed ID: 30847551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fullerene-based multi-functional nanoplatform for cancer theranostic applications.
    Shi J; Wang L; Gao J; Liu Y; Zhang J; Ma R; Liu R; Zhang Z
    Biomaterials; 2014 Jul; 35(22):5771-84. PubMed ID: 24746227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
    Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
    Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional reduction-responsive SPIO&DOX-loaded PEGylated polymeric lipid vesicles for magnetic resonance imaging-guided drug delivery.
    Wang S; Yang W; Du H; Guo F; Wang H; Chang J; Gong X; Zhang B
    Nanotechnology; 2016 Apr; 27(16):165101. PubMed ID: 26941226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
    Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
    Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-functional core-shell Fe
    S R; M P
    Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
    J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.